Histopathological evidences of the nephritic pathological alterations induced by the anabolic androgenic drug (sustanon) in male guinea pigs (Cavia porcellus)

Journal of Biological Sciences

Volumn 9, Issue 6, 2009, Pages 514-523

  Bisher, A S Ahmed Bin ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Abuse; Anabolic androgenic drugs; Histopathological damages; Nephritic; Sustanon

Indexed keywords

TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; DRUG ABUSE; GLOMERULOPATHY; GUINEA PIG; HISTOPATHOLOGY; KIDNEY HEMORRHAGE; KIDNEY INJURY; KIDNEY TUBULE DISORDER; MALE; NONHUMAN; TOXICITY TESTING;

ANIMALIA; CAVIA; CAVIA PORCELLUS;

EID: 67650690672     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2009.514.523     Document Type: Article

References (33)

1. Al-Tayib, Y.A., 2004. The effect of melatonin on molybdenum hydroxylases activities of kidney and small intestine of guinea pigs. J. Egypt. Germ. Soci. Zool., 43A: 203-213.
2. Behrendt, H. and H. Boffin, 2004. Myocardial cell lesions caused by an anabolic drugs abuse. Cell Tissue Res., 181: 423-426.
3. Beota A., 2005. Drug Abuse in Sport. Control Center of Sports Authority of Indian, New Delhi, India.
4. Culling, C.F.A., 1974. Hand Book of Histopathological and Histochemical Techniques. 3rd Edn., Trowbridge and Esher, New York.
5. Draisci, R., L. Palleschi, E. Ferretti and P. Cammarata, 2000. Quantitation of anabolic Hormones and their metabolites in bovine Serum and urine by liquid chromatography Trandem mass spectrometry. J. Chematogap. Analysis., 99: 1293-1293.
6. Fineschi, V., I. Riezzo, F. Centini, E. Silingardi, M. Licata, G. Beduschi and S.B. Karch, 2007. Sudden cardiac death during anabolic steroid abuse: Morphologic and toxicologic findings in two fatal cases of bodybuilders. Int. J. Legal Med., 121: 48-53.
7. Fitch, K,D., 2008. Androgenic-anabolic steroids and the Olympic games. Asian J. Androl., 10: 384-390.
8. Habscheid, W., U. Abele and H.H. Dahm, 1999. Severe cholestasis with kidney failure from Anabolic steroids in bodybuilder. J. Dtsch. Med. Wochenschr, 124: 1029-1029.
9. Hartgens, F. and H. Kuipers, 2004. Effects of Androgenic-anabolic steroids in athletes. J. Sport Med., 34: 513-522.
10. Hartung, R., J Gerth, R. Fünfstück and G. Stein, 2001. End-stage renal disease in a bodybuilder: A multifactorial process or simply doping?. J. Nephrol. Dial. Transplant., 16: 163-165.
11. Harvey, R.A. and P.C. Champe, 2002. The Lippincotts Illustrated Reviews of Pharmacology. 2nd Edn., JB Lippincott Co., New York, USA..
12. Hausmann R., S, Hammer and P. Betz, 1998. Performance enhancing drugs (doping agents) and sudden death: A case report and review of the literature. Int. J. Legal Med., 111: 261-264.
13. Hoseini, L., J. Roozbeb, M. Saqheb and A. Noorafshan, 2009, Nandrolone decanoate increases the volume but not the length of the proximal and distal convoluted tubules of mouse kidney. Micron. L., 40: 226-230.
14. Johansson, S.P., F.G. Nyberg and L. Chahl, 2002. The anabolic androgenic steroid, nandrolone decanoate, increase the density of fos-like immunoreactive neurons in limbic regions of guinea pigs brain. Eurp. J. Neurosci., 15: 539-544.
15. Karch, S.B., 1997. Drugs Abuse Hand Book. 3th Edn., CRC Press, London, UK., ISBN-10: 0849316901.
16. Karila, T., 2003. Adverse Effects of Anabolic Androgenic Steroids on the Cardiovascular, Metabolic and Reproductive Systems of Anabolic Substance Abusers. University of Helsinki Press, Helsinki.
17. Kennedy, M.C and C.F. Lawrence, 1993. Anabolic steroid abuse and cardiac death. Med. J. Australian, 158: 346-346.
18. Kindermann, W., 2006. Cardiovascular side effects of anabolic-androgenic steroids. J. Herz., 31: 566-573.
19. Lenehan, P., 2003. Anabolic Steroids. 2nd Edn., Taylor and Francis Inc., New York. USA., ISBN-10: 0415280303.
20. Modlinski, R. and K. Fields, 2006. The effect of Anabolic steroids on gastrointestinal system, Kidneys and adrenal glands. J. Curr. Sport Med. Rep., 5: 104-109.
21. Monaghan, L., 2001. Bodybuiling, Drugs and Risk. 1st Edn., Taylor and Francis Inc., New York, USA., ISBN-10: 041522683X.
22. Ryan, C. and L. Richard, 2005. Abuse of supraphysiologic doses of anabolic steroids. Southern Med. J., 98: 555-555.
23. Segura, J., S. Pichini, S. Peng and D. Torre, 2000. Hair analysis and delectability of single dose Administration of androgenic steroid ester. J. Forensic Sci. Int., 107: 347-59.
24. Socas, L., M. Zumbado, A. Romos, J. Hernandez and L. Boada, 2005. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in body builders; A report of two cases and a review of the literature. Br. J. Sport Med., 39: 27-41.
25. Stimac, D., S. Miliæ, R.D. Dintinjana, D. Kovac and S. Ristiæ, 2002. Aodrogenic anabolic steroids induced toxic hepatitis. J. Clin. Gastrointerol., 35: 350-352.
26. Tahtamouni, L., N. Mustafa, A. Al-Muthana, I. Hassan, M. Abdalla and S. Yasin, 2008. Prevalence and risk factors for anabolic androgenic steroid abuse among Jordanian collegiate students and athletes. Eurp. J. Pub. Health. 28: 661-665.
27. Urhausen, A., T. Albers and W. Tindermann, 2004. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart J., 90: 496-501.
28. Welder, A., J. Robertson and R. Melchert, 1995. Toxic effects of anabolic-androgenic Steroids in primary rat hepatic cell culture, J. Pharmacol. Toxicol. Methods., 33: 187-195.
29. Wills, S., 2005. Drugs of Abuse. 2nd Edn., Pharmaceutical Press, London, UK., ISBN-10: 0853695822.
30. Wu, F. and A.V. Eckardstein, 1997. Androgens and coronary artery disease. Endocrinol. Rev., 24: 183-217.
31. Yesalis, C.E., 2000. Anabolic Steroids in Sport and Exercise. Human Kinetics. New York, USA., ISBN-10: 0880117869.
32. Zaugg, M., N. Jamali, E. Lucchinerri, S. Shafiq and M. Siddiqi, 2001. Anabolic androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J. Cellular Physiol., 187: 90-95.
33. Zeier, M., R. Schönherr, K. Amann and E, Ritz, 1998. Effects of testosterone on glomerular growth after uninephrectomy. Nephrol Dial. Transplant., 13: 2234-2240.